Medical Futurist October 6, 2020
In January of this year, oblivious of the fact that we were about to engage in a twisted round of real-life Jumanji, we released our annual digital health trends e-book. Among one of our 12 forecasts for 2020 was that at-home blood tests would gain traction and become the new direct-to-consumer DNA testing in terms of adoption and availability. While the pandemic threw everyone off guard and messed up regular forecasts, we might have been onto something with our predicted trend.
With the need to limit physical contact and trace COVID-positive individuals rapidly, public health authorities worldwide are finding rapid, point-of-care (POC) tests for the novel coronavirus increasingly attractive. Whether it’s for testing antibodies or antigens, regulatory authorities are issuing...
Today's Sponsors
Today's Sponsor